Log in

4593 Healios KK TSE · Japan

Healios KK (4593) news

Healios KK is a public biotech or pharmaceutical company listed on TSE under the ticker 4593, recorded under Japan. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Healios KK news

We have not published a story on Healios KK yet. When there is news, it will appear here.

Questions about Healios KK

What is the ticker symbol of Healios KK?

Healios KK trades under the ticker 4593 on TSE.

Where is Healios KK listed?

Healios KK is listed on TSE. Our directory also records these other listings: LSX:A14U80.

Which country or territory is Healios KK listed under?

Our directory records Healios KK under Japan.

What does Healios KK do?

Our directory classifies Healios KK as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Healios KK?

The ISIN recorded for Healios KK is JP3835100003.

Does aibio.space cover Healios KK?

aibio.space lists Healios KK among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Healios KK?

Companies in our directory listed in the same country and business area as Healios KK: Kaken Pharmaceutical Co., SAWAI GROUP HOLDINGS Co., Chugai Pharmaceutical Co., Fuji Pharma Co., Zeria Pharmaceutical Co., Ribomic.

Investor discussion: Healios KK

Members talk about Healios KK (4593). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TSE:4593 on TradingView.

Listing details

Healios KK is a public biotech or pharmaceutical company listed on TSE under the ticker 4593, recorded under Japan. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Healios KK
Ticker
4593
Listing
TSE
Country or territory
Japan
Business scope
Pharmaceuticals: Major
ISIN
JP3835100003
Other listed symbols
LSX:A14U80
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.